Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 31, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012986.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid phosphatase-related protein type 3a
zinc finger protein 239-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
zinc finger protein 239-like, transcript variant X1
zinc finger protein 239-like, transcript variant X2
AP-1 complex subunit mu-1, transcript variant X1
AP-1 complex subunit mu-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
family with sequence similarity 32 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X5
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X8
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X7
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X6
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X2
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X4
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X3
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X14
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X12
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X1
epidermal growth factor receptor substrate 15-like 1 isoform X5
epidermal growth factor receptor substrate 15-like 1 isoform X8
epidermal growth factor receptor substrate 15-like 1 isoform X7
epidermal growth factor receptor substrate 15-like 1 isoform X6
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X4
epidermal growth factor receptor substrate 15-like 1 isoform X3
epidermal growth factor receptor substrate 15-like 1 isoform X13
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X13
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X10
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X9
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X11
epidermal growth factor receptor substrate 15-like 1 isoform X12
epidermal growth factor receptor substrate 15-like 1 isoform X10
epidermal growth factor receptor substrate 15-like 1 isoform X9
epidermal growth factor receptor substrate 15-like 1 isoform X11
UV excision repair protein RAD23 homolog B-like, transcript variant X2
UV excision repair protein RAD23 homolog B-like, transcript variant X3
UV excision repair protein RAD23 homolog B-like, transcript variant X1
UV excision repair protein RAD23 homolog B-like isoform X2
UV excision repair protein RAD23 homolog B-like isoform X3
UV excision repair protein RAD23 homolog B-like isoform X1
chromosome 31 C19orf44 homolog, transcript variant X7
chromosome 31 C19orf44 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 31 C19orf44 homolog, transcript variant X5
chromosome 31 C19orf44 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromosome 31 C19orf44 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome 31 C19orf44 homolog, transcript variant X1
chromosome 31 C19orf44 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein C19orf44 homolog isoform X1
uncharacterized protein C19orf44 homolog isoform X2
uncharacterized protein C19orf44 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium homeostasis endoplasmic reticulum protein, transcript variant X3
calcium homeostasis endoplasmic reticulum protein, transcript variant X2
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein isoform X3
calcium homeostasis endoplasmic reticulum protein isoform X2
calcium homeostasis endoplasmic reticulum protein isoform X1
solute carrier family 35 member E1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122565135, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122565135, transcript variant X3
uncharacterized LOC122565135, transcript variant X2
solute carrier family 35 member E1, transcript variant X1
cofactor required for Sp1 transcriptional activation, subunit 7, transcript variant X1
cofactor required for Sp1 transcriptional activation, subunit 7, transcript variant X2
mediator of RNA polymerase II transcription subunit 26 isoform X1
mediator of RNA polymerase II transcription subunit 26 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
trimeric intracellular cation channel type A
zinc finger protein 462-like, transcript variant X1
zinc finger protein 462-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
scaffold attachment factor B, transcript variant X3
scaffold attachment factor B, transcript variant X1
scaffold attachment factor B1 isoform X3
scaffold attachment factor B1 isoform X1
scaffold attachment factor B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
scaffold attachment factor B1 isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
small nucleolar RNA SNORA42/SNORA80 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00406
uncharacterized LOC122565142, transcript variant X2
uncharacterized LOC122565142, transcript variant X1
uncharacterized LOC122565142, transcript variant X3
uncharacterized LOC122565142, transcript variant X4
uncharacterized protein LOC122565142 isoform X2
uncharacterized protein LOC122565142 isoform X1
uncharacterized protein LOC122565142 isoform X3
uncharacterized protein LOC122565142 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
serine/threonine-protein kinase WNK3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
serine/threonine-protein kinase WNK3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase WNK3-like, transcript variant X2
serine/threonine-protein kinase WNK3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
serine/threonine-protein kinase WNK3-like
disintegrin and metalloproteinase domain-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
scaffold attachment factor B1-like, transcript variant X1
scaffold attachment factor B1-like isoform X1
scaffold attachment factor B1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
scaffold attachment factor B1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
scaffold attachment factor B1-like, transcript variant X4
scaffold attachment factor B1-like isoform X3
scaffold attachment factor B1-like isoform X2
regulatory factor X, 2 (influences HLA class II expression), transcript variant X2
regulatory factor X, 2 (influences HLA class II expression), transcript variant X1
regulatory factor X, 2 (influences HLA class II expression), transcript variant X4
regulatory factor X, 2 (influences HLA class II expression), transcript variant X3
regulatory factor X, 2 (influences HLA class II expression), transcript variant X5
potassium voltage-gated channel subfamily V member 2-like
very low-density lipoprotein receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
A-kinase anchor protein 2-like, transcript variant X1
A-kinase anchor protein 2-like, transcript variant X3
A-kinase anchor protein 2-like, transcript variant X2
A-kinase anchor protein 2-like isoform X1
A-kinase anchor protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
polypyrimidine tract-binding protein 1-like, transcript variant X8
polypyrimidine tract-binding protein 1-like, transcript variant X6
polypyrimidine tract-binding protein 1-like, transcript variant X4
polypyrimidine tract-binding protein 1-like, transcript variant X2
polypyrimidine tract-binding protein 1-like, transcript variant X7
polypyrimidine tract-binding protein 1-like, transcript variant X5
polypyrimidine tract-binding protein 1-like, transcript variant X3
polypyrimidine tract-binding protein 1-like, transcript variant X1
polypyrimidine tract-binding protein 1-like isoform X8
polypyrimidine tract-binding protein 1-like isoform X6
polypyrimidine tract-binding protein 1-like isoform X4
polypyrimidine tract-binding protein 1-like isoform X2
polypyrimidine tract-binding protein 1-like isoform X7
polypyrimidine tract-binding protein 1-like isoform X5
polypyrimidine tract-binding protein 1-like isoform X3
polypyrimidine tract-binding protein 1-like isoform X1
WD repeat domain 55, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat domain 55, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat domain 55, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat domain 55, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat-containing protein 55 isoform X1
WD repeat-containing protein 55 isoform X2
WD repeat-containing protein 55 isoform X3
vimentin-type intermediate filament-associated coiled-coil protein-like
uncharacterized LOC122565157, transcript variant X2
uncharacterized LOC122565157, transcript variant X1
uncharacterized protein LOC122565157 isoform X2
uncharacterized protein LOC122565157 isoform X1
Tax1 (human T-cell leukemia virus type I) binding protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium and integrin binding family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
calcium and integrin-binding family member 3
cell surface glycoprotein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell surface glycoprotein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cell surface glycoprotein 1-like isoform X2
cell surface glycoprotein 1-like isoform X1
E3 ubiquitin-protein ligase arkadia-A-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin-protein ligase arkadia-A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
E3 ubiquitin-protein ligase arkadia-A-like, transcript variant X1
E3 ubiquitin-protein ligase arkadia-A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
E3 ubiquitin-protein ligase arkadia-A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
E3 ubiquitin-protein ligase arkadia-A-like isoform X1
E3 ubiquitin-protein ligase arkadia-B-like isoform X2
E3 ubiquitin-protein ligase arkadia-A-like isoform X3
NDC80 kinetochore complex component, transcript variant X2
NDC80 kinetochore complex component, transcript variant X1
kinetochore protein NDC80 homolog isoform X1
kinetochore protein NDC80 homolog isoform X2
interleukin-27 subunit beta-like, transcript variant X2
interleukin-27 subunit beta-like, transcript variant X1
ankyrin repeat domain-containing protein 24-like, transcript variant X2
ankyrin repeat domain-containing protein 24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat domain-containing protein 24-like isoform X2
ankyrin repeat domain-containing protein 24-like isoform X1
NAD-dependent protein deacetylase sirtuin-6 isoform X1
NAD-dependent protein deacetylase sirtuin-6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cyclic AMP-responsive element-binding protein 3-like protein 3
dual specificity mitogen-activated protein kinase kinase 2
zinc finger and BTB domain-containing protein 7A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 7A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 7A-like isoform X1
zinc finger and BTB domain-containing protein 7A-like isoform X2
E3 SUMO-protein ligase PIAS4-like, transcript variant X1
E3 SUMO-protein ligase PIAS4-like isoform X1
E3 SUMO-protein ligase PIAS4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 SUMO-protein ligase PIAS4-like isoform X2
E3 SUMO-protein ligase PIAS4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 SUMO-protein ligase PIAS4-like isoform X3
death-associated protein kinase 3, transcript variant X3
death-associated protein kinase 3, transcript variant X4
death-associated protein kinase 3, transcript variant X2
death-associated protein kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 154 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
procathepsin L-like, transcript variant X1
procathepsin L-like, transcript variant X2
procathepsin L-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dipeptidyl-peptidase 9, transcript variant X1
dipeptidyl-peptidase 9, transcript variant X2
dipeptidyl-peptidase 9, transcript variant X3
dipeptidyl-peptidase 9, transcript variant X5
dipeptidyl-peptidase 9, transcript variant X7
dipeptidyl-peptidase 9, transcript variant X6
dipeptidyl-peptidase 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X1
ELAV-like protein 1, transcript variant X2
uncharacterized LOC122565192, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122565192, transcript variant X1
uncharacterized LOC122565192, transcript variant X2
uncharacterized LOC122565192, transcript variant X3
immunoglobulin lambda variable 5-45-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
immunoglobulin lambda-1 light chain-like, transcript variant X3
immunoglobulin lambda-1 light chain-like, transcript variant X2
immunoglobulin lambda-1 light chain-like, transcript variant X1
immunoglobulin lambda-1 light chain-like isoform X3
immunoglobulin lambda-1 light chain-like isoform X2
immunoglobulin lambda-1 light chain-like isoform X1
immunoglobulin lambda variable 5-37-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin lambda variable 5-37-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
immunoglobulin lambda variable 5-37-like isoform X3
ribosomal protein L37, transcript variant X1
ribosomal protein L37, transcript variant X2
TIR domain-containing adapter molecule 1
arrestin domain-containing protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
arrestin domain-containing protein 5-like
arrestin domain-containing protein 5-like, transcript variant X2
ubiquitin-like with PHD and ring finger domains 1
lysine (K)-specific demethylase 4B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine (K)-specific demethylase 4B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysine (K)-specific demethylase 4B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
lysine (K)-specific demethylase 4B, transcript variant X7
lysine (K)-specific demethylase 4B, transcript variant X1
lysine (K)-specific demethylase 4B, transcript variant X5
lysine (K)-specific demethylase 4B, transcript variant X3
lysine (K)-specific demethylase 4B, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
lysine (K)-specific demethylase 4B, transcript variant X4
lysine-specific demethylase 4B isoform X1
lysine-specific demethylase 4B isoform X3
lysine-specific demethylase 4B isoform X2
lysine-specific demethylase 4B isoform X4
lysine-specific demethylase 4B isoform X5
receptor-type tyrosine-protein phosphatase S-like, transcript variant X3
receptor-type tyrosine-protein phosphatase S-like, transcript variant X7
receptor-type tyrosine-protein phosphatase S-like, transcript variant X8
receptor-type tyrosine-protein phosphatase S-like, transcript variant X15
receptor-type tyrosine-protein phosphatase S-like, transcript variant X6
receptor-type tyrosine-protein phosphatase S-like, transcript variant X2
receptor-type tyrosine-protein phosphatase S-like, transcript variant X14
receptor-type tyrosine-protein phosphatase S-like, transcript variant X5
receptor-type tyrosine-protein phosphatase S-like, transcript variant X13
receptor-type tyrosine-protein phosphatase S-like, transcript variant X1
receptor-type tyrosine-protein phosphatase S-like, transcript variant X12
receptor-type tyrosine-protein phosphatase S-like, transcript variant X9
receptor-type tyrosine-protein phosphatase S-like, transcript variant X11
receptor-type tyrosine-protein phosphatase S-like, transcript variant X4
receptor-type tyrosine-protein phosphatase S-like, transcript variant X18
receptor-type tyrosine-protein phosphatase S-like, transcript variant X17
receptor-type tyrosine-protein phosphatase S-like, transcript variant X10
receptor-type tyrosine-protein phosphatase S-like, transcript variant X16
receptor-type tyrosine-protein phosphatase delta-like isoform X12
receptor-type tyrosine-protein phosphatase delta-like isoform X9
receptor-type tyrosine-protein phosphatase delta-like isoform X3
receptor-type tyrosine-protein phosphatase delta-like isoform X11
receptor-type tyrosine-protein phosphatase delta-like isoform X7
receptor-type tyrosine-protein phosphatase delta-like isoform X4
receptor-type tyrosine-protein phosphatase S-like isoform X18
receptor-type tyrosine-protein phosphatase S-like isoform X17
receptor-type tyrosine-protein phosphatase delta-like isoform X10
receptor-type tyrosine-protein phosphatase delta-like isoform X8
receptor-type tyrosine-protein phosphatase delta-like isoform X15
receptor-type tyrosine-protein phosphatase delta-like isoform X6
receptor-type tyrosine-protein phosphatase delta-like isoform X2
receptor-type tyrosine-protein phosphatase delta-like isoform X14
receptor-type tyrosine-protein phosphatase delta-like isoform X5
receptor-type tyrosine-protein phosphatase delta-like isoform X13
receptor-type tyrosine-protein phosphatase delta-like isoform X1
receptor-type tyrosine-protein phosphatase delta-like isoform X16
receptor-type tyrosine-protein phosphatase S-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122565082, transcript variant X2
uncharacterized LOC122565082, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
YJU2 splicing factor homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
YJU2 splicing factor homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
YJU2 splicing factor homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SH2 domain-containing adapter protein F-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SH2 domain-containing adapter protein F-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SH2 domain-containing adapter protein D-like isoform X1
SH2 domain-containing adapter protein F-like isoform X2
cytotoxic T-lymphocyte protein 4-like, transcript variant X2
cytotoxic T-lymphocyte protein 4-like, transcript variant X1
cytotoxic T-lymphocyte protein 4-like isoform X1
cytotoxic T-lymphocyte protein 4-like isoform X2
fibronectin type III and SPRY domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fibronectin type III and SPRY domain-containing protein 1
uncharacterized LOC122565212, transcript variant X2
signal-transducing adaptor protein 1-like, transcript variant X3
signal-transducing adaptor protein 1-like, transcript variant X2
signal-transducing adaptor protein 1-like, transcript variant X1
signal-transducing adaptor protein 1-like isoform X3
signal-transducing adaptor protein 1-like isoform X2
signal-transducing adaptor protein 1-like isoform X1
uncharacterized LOC122565212, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SH3-domain GRB2-like 1b, transcript variant X2
SH3-domain GRB2-like 1b, transcript variant X1
chromatin assembly factor 1, subunit A (p150), transcript variant X5
chromatin assembly factor 1, subunit A (p150), transcript variant X2
chromatin assembly factor 1, subunit A (p150), transcript variant X1
chromatin assembly factor 1 subunit A isoform X1
chromatin assembly factor 1 subunit A isoform X2
chromatin assembly factor 1, subunit A (p150), transcript variant X3
chromatin assembly factor 1 subunit A isoform X3
chromatin assembly factor 1, subunit A (p150), transcript variant X4
chromatin assembly factor 1 subunit A isoform X5
chromatin assembly factor 1 subunit A isoform X4
UBX domain protein 6, transcript variant X1
UBX domain protein 6, transcript variant X2
UBX domain-containing protein 6 isoform X1
UBX domain-containing protein 6 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
hepatoma-derived growth factor-related protein 2 isoform X1
hepatoma-derived growth factor-related protein 2 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X3
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6Bb, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6Bb, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6Bb, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6Bb, transcript variant X5
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6Bb, transcript variant X4
tumor necrosis factor, alpha-induced protein 8-like 1, transcript variant X2
tumor necrosis factor, alpha-induced protein 8-like 1, transcript variant X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein-lysine 6-oxidase-like, transcript variant X2
protein-lysine 6-oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein-lysine 6-oxidase-like isoform X2
protein-lysine 6-oxidase-like isoform X1
muscle-specific beta 1 integrin binding protein, transcript variant X1
muscle-specific beta 1 integrin binding protein, transcript variant X2
muscle-specific beta 1 integrin binding protein isoform X1
muscle-specific beta 1 integrin binding protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
zinc finger RNA-binding protein-like, transcript variant X5
zinc finger RNA-binding protein-like, transcript variant X3
zinc finger RNA-binding protein-like, transcript variant X2
zinc finger RNA-binding protein-like, transcript variant X1
zinc finger RNA-binding protein-like, transcript variant X4
zinc finger RNA-binding protein-like isoform X1
zinc finger RNA-binding protein-like isoform X3
zinc finger RNA-binding protein-like isoform X2
zinc finger RNA-binding protein-like isoform X4
zinc finger RNA-binding protein-like isoform X5
megakaryocyte-associated tyrosine-protein kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
megakaryocyte-associated tyrosine-protein kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
megakaryocyte-associated tyrosine-protein kinase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
retinal homeobox gene 1, transcript variant X2
retinal homeobox gene 1, transcript variant X1
retinal homeobox gene 1, transcript variant X3
MALT paracaspase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MALT paracaspase 2, transcript variant X2
repetitive proline-rich cell wall protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L54, mitochondrial
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like, transcript variant X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like, transcript variant X5
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like, transcript variant X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like, transcript variant X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like, transcript variant X1
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma-like isoform X1
tight junction protein ZO-3-like, transcript variant X1
tight junction protein ZO-3-like, transcript variant X2
tight junction protein ZO-3-like isoform X1
tight junction protein ZO-3-like isoform X2
amyloid-beta A4 precursor protein-binding family A member 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
amyloid-beta A4 precursor protein-binding family A member 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
amyloid-beta A4 precursor protein-binding family A member 1-like isoform X2
amyloid-beta A4 precursor protein-binding family A member 1-like isoform X1
phospholipid-transporting ATPase ABCA1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid-transporting ATPase ABCA1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid-transporting ATPase ABCA1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipid-transporting ATPase ABCA1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipid-transporting ATPase ABCA1-like isoform X1
phospholipid-transporting ATPase ABCA1-like isoform X2
phospholipid-transporting ATPase ABCA1-like isoform X4
phospholipid-transporting ATPase ABCA1-like isoform X3
basic proline-rich protein-like, transcript variant X2
basic proline-rich protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
proline-rich receptor-like protein kinase PERK10 isoform X2
basic proline-rich protein-like isoform X1
basic proline-rich protein-like, transcript variant X3
basic proline-rich protein-like isoform X3
transmembrane protein 259, transcript variant X1
transmembrane protein 259, transcript variant X2
transmembrane protein 259, transcript variant X3
glutamate receptor, ionotropic, N-methyl-D-aspartate 3Bb
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
AT rich interactive domain 3A (BRIGHT-like), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
AT rich interactive domain 3A (BRIGHT-like), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
AT-rich interactive domain-containing protein 3A isoform X2
AT-rich interactive domain-containing protein 3A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
R3H domain containing 4, transcript variant X1
R3H domain-containing protein 4 isoform X1
R3H domain containing 4, transcript variant X2
R3H domain-containing protein 4 isoform X2
iron-sulfur cluster assembly 1 homolog, mitochondrial-like
mediator of RNA polymerase II transcription subunit 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
la-related protein 6-like, transcript variant X4
la-related protein 6-like, transcript variant X5
la-related protein 6-like, transcript variant X6
la-related protein 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
la-related protein 6-like, transcript variant X2
la-related protein 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane-associated ring finger (C3HC4) 2
heterogeneous nuclear ribonucleoprotein M-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein M-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein M-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein M-like, transcript variant X4
heterogeneous nuclear ribonucleoprotein M-like isoform X1
heterogeneous nuclear ribonucleoprotein M-like isoform X2
heterogeneous nuclear ribonucleoprotein M-like isoform X3
heterogeneous nuclear ribonucleoprotein M-like isoform X4
heterogeneous nuclear ribonucleoprotein M-like, transcript variant X5
heterogeneous nuclear ribonucleoprotein M-like isoform X5
translocase of inner mitochondrial membrane 44 homolog (yeast)
mitochondrial import inner membrane translocase subunit TIM44
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CDC42 small effector protein 2-like, transcript variant X2
CDC42 small effector protein 2-like, transcript variant X1
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm7
signal peptide peptidase-like 2, transcript variant X1
signal peptide peptidase-like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
signal peptide peptidase-like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
signal peptide peptidase-like 2 isoform X1
signal peptide peptidase-like 2 isoform X3
signal peptide peptidase-like 2, transcript variant X2
signal peptide peptidase-like 2 isoform X2
translocase of inner mitochondrial membrane 13 homolog (yeast)
mitochondrial import inner membrane translocase subunit Tim13
dedicator of cytokinesis protein 7-like, transcript variant X1
dedicator of cytokinesis protein 7-like, transcript variant X2
dedicator of cytokinesis protein 7-like isoform X1
dedicator of cytokinesis protein 7-like isoform X2
KN motif and ankyrin repeat domains 3, transcript variant X1
KN motif and ankyrin repeat domains 3, transcript variant X2
KN motif and ankyrin repeat domain-containing protein 3
NADH:ubiquinone oxidoreductase subunit A7, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 isoform X2
NADH:ubiquinone oxidoreductase subunit A7, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 isoform X1
chemokine (C-C motif) ligand 25b, transcript variant X1
chemokine (C-C motif) ligand 25b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
polymerase (DNA-directed), epsilon 4, accessory subunit, transcript variant X3
polymerase (DNA-directed), epsilon 4, accessory subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
DNA polymerase epsilon subunit 4 isoform X2
polymerase (DNA-directed), epsilon 4, accessory subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
DNA polymerase epsilon subunit 4 isoform X1
serine/threonine-protein kinase NIM1-like, transcript variant X1
serine/threonine-protein kinase NIM1-like, transcript variant X2
serine/threonine-protein kinase NIM1-like
NADH:ubiquinone oxidoreductase subunit A11
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glial cell line-derived neurotrophic factor isoform X1
glial cell line-derived neurotrophic factor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ran-binding protein 3-like, transcript variant X2
ran-binding protein 3-like, transcript variant X1
ran-binding protein 3-like, transcript variant X3
ran-binding protein 3-like, transcript variant X4
acidic leucine-rich nuclear phosphoprotein 32 family member D-like
alkaline ceramidase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alkaline ceramidase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MLLT1 super elongation complex subunit a, transcript variant X3
MLLT1 super elongation complex subunit a, transcript variant X1
MLLT1 super elongation complex subunit a, transcript variant X2
acyl-CoA synthetase bubblegum family member 2, transcript variant X3
acyl-CoA synthetase bubblegum family member 2, transcript variant X2
acyl-CoA synthetase bubblegum family member 2, transcript variant X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase ZAP-70, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tyrosine-protein kinase ZAP-70, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor interleukin-3-regulated protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 150 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 799 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2
nuclear factor I/C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor I/C, transcript variant X2
nuclear factor I/C, transcript variant X4
nuclear factor I/C, transcript variant X1
nuclear factor I/C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X2
fizzy/cell division cycle 20 related 1a, transcript variant X1
fizzy/cell division cycle 20 related 1a, transcript variant X2
fizzy/cell division cycle 20 related 1a isoform X1
fizzy/cell division cycle 20 related 1a isoform X2
MOB kinase activator 3A, transcript variant X2
MOB kinase activator 3A, transcript variant X4
MOB kinase activator 3A, transcript variant X3
MOB kinase activator 3A, transcript variant X1
uncharacterized LOC122565095, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122565095, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
MAPK interacting serine/threonine kinase 2b, transcript variant X2
MAPK interacting serine/threonine kinase 2b, transcript variant X1
MAP kinase-interacting serine/threonine-protein kinase 2b isoform X1
MAP kinase-interacting serine/threonine-protein kinase 2b isoform X2
MAPK interacting serine/threonine kinase 2b, transcript variant X3
MAP kinase-interacting serine/threonine-protein kinase 2b isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
high mobility group 20B, transcript variant X4
high mobility group 20B, transcript variant X1
high mobility group 20B, transcript variant X2
high mobility group 20B, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related isoform X2
protein unc-13 homolog A, transcript variant X12
protein unc-13 homolog A, transcript variant X3
protein unc-13 homolog A, transcript variant X4
protein unc-13 homolog A, transcript variant X1
protein unc-13 homolog A, transcript variant X5
protein unc-13 homolog A, transcript variant X6
protein unc-13 homolog A, transcript variant X2
protein unc-13 homolog A, transcript variant X13
protein unc-13 homolog A, transcript variant X11
protein unc-13 homolog A, transcript variant X17
protein unc-13 homolog A, transcript variant X7
protein unc-13 homolog A, transcript variant X10
protein unc-13 homolog A, transcript variant X8
protein unc-13 homolog A, transcript variant X9
protein unc-13 homolog A, transcript variant X15
protein unc-13 homolog A, transcript variant X14
protein unc-13 homolog A, transcript variant X16
protein unc-13 homolog A, transcript variant X18
methyl-CpG binding domain protein 3a, transcript variant X3
methyl-CpG binding domain protein 3a, transcript variant X6
methyl-CpG binding domain protein 3a, transcript variant X4
methyl-CpG binding domain protein 3a, transcript variant X1
methyl-CpG binding domain protein 3a, transcript variant X5
methyl-CpG binding domain protein 3a, transcript variant X2
methyl-CpG-binding domain protein 3a isoform X6
methyl-CpG-binding domain protein 3a isoform X3
methyl-CpG-binding domain protein 3a isoform X5
methyl-CpG-binding domain protein 3a isoform X4
methyl-CpG-binding domain protein 3a isoform X2
methyl-CpG-binding domain protein 3a isoform X1
one cut homeobox 3b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
one cut homeobox 3b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
one cut homeobox 3b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
one cut domain family member 2 isoform X1
one cut domain family member 2 isoform X3
one cut domain family member 2 isoform X2
ATPase phospholipid transporting 8B3, transcript variant X8
ATPase phospholipid transporting 8B3, transcript variant X1
ATPase phospholipid transporting 8B3, transcript variant X5
ATPase phospholipid transporting 8B3, transcript variant X3
ATPase phospholipid transporting 8B3, transcript variant X7
ATPase phospholipid transporting 8B3, transcript variant X4
ATPase phospholipid transporting 8B3, transcript variant X6
ATPase phospholipid transporting 8B3, transcript variant X2
phospholipid-transporting ATPase IC isoform X2
phospholipid-transporting ATPase IC isoform X1
ATPase phospholipid transporting 8B3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phospholipid-transporting ATPase IC isoform X3
ATPase phospholipid transporting 8B3, transcript variant X10
phospholipid-transporting ATPase IC isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
thromboxane A2 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
thromboxane A2 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GIPC PDZ domain containing family, member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GIPC PDZ domain containing family, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
PDZ domain-containing protein GIPC3 isoform X2
PDZ domain-containing protein GIPC3 isoform X1
PEAK family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
inactive tyrosine-protein kinase PEAK1 isoform X1
PEAK family member 3, transcript variant X2
inactive tyrosine-protein kinase PEAK1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1a
uncharacterized LOC122565325, transcript variant X1
uncharacterized LOC122565325, transcript variant X2
uncharacterized protein LOC122565325 isoform X1
uncharacterized protein LOC122565325 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
splicing factor 3a, subunit 2, transcript variant X2
splicing factor 3a, subunit 2, transcript variant X1
pleckstrin homology domain containing, family J member 1, transcript variant X1
pleckstrin homology domain containing, family J member 1, transcript variant X2
pleckstrin homology domain-containing family J member 1 isoform X1
pleckstrin homology domain-containing family J member 1 isoform X2
pleckstrin homology domain containing, family J member 1, transcript variant X3
pleckstrin homology domain-containing family J member 1 isoform X3
DOT1-like histone H3K79 methyltransferase, transcript variant X2
DOT1-like histone H3K79 methyltransferase, transcript variant X6
DOT1-like histone H3K79 methyltransferase, transcript variant X1
DOT1-like histone H3K79 methyltransferase, transcript variant X5
DOT1-like histone H3K79 methyltransferase, transcript variant X4
DOT1-like histone H3K79 methyltransferase, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X6
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X4
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X5
uncharacterized LOC122565098, transcript variant X1
uncharacterized LOC122565098, transcript variant X2
adaptor related protein complex 3 subunit delta 1, transcript variant X1
adaptor related protein complex 3 subunit delta 1, transcript variant X2
uncharacterized LOC122565332, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122565332, transcript variant X1
uncharacterized protein LOC122565332 isoform X1
uncharacterized protein LOC122565332 isoform X2
diencephalon/mesencephalon homeobox protein 1-like, transcript variant X2
diencephalon/mesencephalon homeobox protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
diencephalon/mesencephalon homeobox protein 1-like
major facilitator superfamily domain containing 12a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
major facilitator superfamily domain-containing protein 12a isoform X1
major facilitator superfamily domain containing 12a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
major facilitator superfamily domain containing 12a, transcript variant X2
major facilitator superfamily domain-containing protein 12a isoform X2
secretory carrier membrane protein 4, transcript variant X1
secretory carrier membrane protein 4, transcript variant X2
secretory carrier membrane protein 4, transcript variant X4
secretory carrier membrane protein 4, transcript variant X3
secretory carrier membrane protein 4, transcript variant X5
secretory carrier-associated membrane protein 4
nuclear receptor ROR-beta-like, transcript variant X3
nuclear receptor ROR-beta-like, transcript variant X2
nuclear receptor ROR-beta-like, transcript variant X1
nuclear receptor ROR-beta-like isoform X3
nuclear receptor ROR-beta-like isoform X2
nuclear receptor ROR-beta-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC405808 homolog, transcript variant X1
AN1-type zinc finger protein 5 isoform X1
uncharacterized protein LOC405808 homolog, transcript variant X2
AN1-type zinc finger protein 5 isoform X2
alpha/beta hydrolase domain-containing protein 17B-like
uncharacterized LOC122565343, transcript variant X1
uncharacterized LOC122565343, transcript variant X2
BTB/POZ domain-containing protein 2-like, transcript variant X1
BTB/POZ domain-containing protein 2-like, transcript variant X2
BTB/POZ domain-containing protein 2-like, transcript variant X3
BTB/POZ domain-containing protein 2-like, transcript variant X4
BTB/POZ domain-containing protein 2-like isoform X1
BTB/POZ domain-containing protein 2-like isoform X3
BTB/POZ domain-containing protein 2-like isoform X2
BTB/POZ domain-containing protein 2-like isoform X4
BTB/POZ domain-containing protein 2-like, transcript variant X5
BTB/POZ domain-containing protein 2-like, transcript variant X6
BTB/POZ domain-containing protein 2-like, transcript variant X7
BTB/POZ domain-containing protein 2-like, transcript variant X8
BTB/POZ domain-containing protein 2-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 45-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 45-like isoform X3
rho GTPase-activating protein 45-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho GTPase-activating protein 45-like, transcript variant X2
rho GTPase-activating protein 45-like isoform X1
rho GTPase-activating protein 45-like isoform X2
uncharacterized LOC122565350, transcript variant X2
uncharacterized LOC122565350, transcript variant X1
outer dense fiber of sperm tails 3-like 2b
outer dense fiber protein 3-like protein 2b
DNA-directed RNA polymerases I, II, and III subunit RPABC1
phospholipid hydroperoxide glutathione peroxidase-like, transcript variant X2
phospholipid hydroperoxide glutathione peroxidase-like isoform X2
phospholipid hydroperoxide glutathione peroxidase-like, transcript variant X5
phospholipid hydroperoxide glutathione peroxidase-like, transcript variant X4
phospholipid hydroperoxide glutathione peroxidase-like isoform X4
phospholipid hydroperoxide glutathione peroxidase-like, transcript variant X1
phospholipid hydroperoxide glutathione peroxidase-like isoform X1
phospholipid hydroperoxide glutathione peroxidase-like, transcript variant X6
phospholipid hydroperoxide glutathione peroxidase-like, transcript variant X3
phospholipid hydroperoxide glutathione peroxidase-like isoform X3
phospholipid hydroperoxide glutathione peroxidase-like isoform X5
protein strawberry notch homolog 2-like, transcript variant X2
protein strawberry notch homolog 2-like, transcript variant X1
protein strawberry notch homolog 2-like, transcript variant X3
protein strawberry notch homolog 2-like isoform X2
protein strawberry notch homolog 2-like isoform X1
protein strawberry notch homolog 2-like isoform X3
serine/threonine kinase 11, transcript variant X2
serine/threonine kinase 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
serine/threonine-protein kinase STK11 isoform X2
serine/threonine-protein kinase STK11 isoform X1
CACN subunit beta associated regulatory protein b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CACN subunit beta associated regulatory protein b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CACN subunit beta associated regulatory protein b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CACN subunit beta associated regulatory protein b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X3
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X1
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X2
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X4
ATP synthase subunit delta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
cold-inducible RNA-binding protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
cold-inducible RNA-binding protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
cold-inducible RNA-binding protein-like, transcript variant X2
cold-inducible RNA-binding protein-like isoform X3
cold-inducible RNA-binding protein-like isoform X2
cold-inducible RNA-binding protein-like isoform X1
cold-inducible RNA-binding protein-like, transcript variant X5
cold-inducible RNA-binding protein-like, transcript variant X8
cold-inducible RNA-binding protein-like, transcript variant X4
cold-inducible RNA-binding protein-like, transcript variant X6
cold-inducible RNA-binding protein-like, transcript variant X12
cold-inducible RNA-binding protein-like, transcript variant X13
cold-inducible RNA-binding protein-like, transcript variant X15
cold-inducible RNA-binding protein-like, transcript variant X16
cold-inducible RNA-binding protein-like, transcript variant X17
cold-inducible RNA-binding protein-like, transcript variant X10
cold-inducible RNA-binding protein-like, transcript variant X11
cold-inducible RNA-binding protein-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cold-inducible RNA-binding protein-like, transcript variant X7
cold-inducible RNA-binding protein-like, transcript variant X9
cold-inducible RNA-binding protein-like isoform X6
cold-inducible RNA-binding protein-like isoform X5
cold-inducible RNA-binding protein-like isoform X4
follistatin-like 3 (secreted glycoprotein), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
follistatin-like 3 (secreted glycoprotein), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
follistatin-like 3 (secreted glycoprotein), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
follistatin-related protein 3 isoform X1
follistatin-related protein 3 isoform X3
follistatin-related protein 3 isoform X2
ring finger protein 126, transcript variant X1
ring finger protein 126, transcript variant X2
E3 ubiquitin-protein ligase RNF126 isoform X1
E3 ubiquitin-protein ligase RNF126 isoform X2
uncharacterized LOC122565368, transcript variant X3
uncharacterized LOC122565368, transcript variant X1
uncharacterized LOC122565368, transcript variant X2
uncharacterized LOC122565368, transcript variant X4
fibroblast growth factor 22, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 22, transcript variant X1
fibroblast growth factor 22, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polymerase (RNA) mitochondrial (DNA directed), transcript variant X3
polymerase (RNA) mitochondrial (DNA directed), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
polymerase (RNA) mitochondrial (DNA directed), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DNA-directed RNA polymerase, mitochondrial isoform X1
DNA-directed RNA polymerase, mitochondrial isoform X2
DNA-directed RNA polymerase, mitochondrial isoform X3
hyperpolarization activated cyclic nucleotide-gated potassium channel 2b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
insulin gene enhancer protein ISL-1-like, transcript variant X1
insulin gene enhancer protein ISL-1-like, transcript variant X3
insulin gene enhancer protein ISL-1-like, transcript variant X2
insulin gene enhancer protein ISL-1-like isoform X1
insulin gene enhancer protein ISL-1-like isoform X3
insulin gene enhancer protein ISL-1-like isoform X2
testicular haploid expressed gene protein-like
mesoderm induction early response protein 2-like
interleukin-6 receptor subunit beta-like, transcript variant X2
interleukin-6 receptor subunit beta-like, transcript variant X1
interleukin-6 receptor subunit beta-like isoform X1
interleukin-6 receptor subunit beta-like, transcript variant X3
interleukin-6 receptor subunit beta-like isoform X2
interleukin-6 receptor subunit beta-like, transcript variant X4
interleukin-6 receptor subunit beta-like isoform X3
phospholipid phosphatase 2-like, transcript variant X1
phospholipid phosphatase 2-like, transcript variant X2
phospholipid phosphatase 2-like, transcript variant X3
transducin-like enhancer protein 1, transcript variant X2
transducin-like enhancer protein 1, transcript variant X1
transducin-like enhancer protein 1, transcript variant X3
transducin-like enhancer protein 1 isoform X1
transducin-like enhancer protein 1 isoform X2
transducin-like enhancer protein 4 isoform X3
transducin-like enhancer protein 4, transcript variant X7
transducin-like enhancer protein 4, transcript variant X2
transducin-like enhancer protein 4, transcript variant X5
transducin-like enhancer protein 4, transcript variant X3
transducin-like enhancer protein 4, transcript variant X1
transducin-like enhancer protein 4, transcript variant X6
transducin-like enhancer protein 4, transcript variant X4
transducin-like enhancer protein 4, transcript variant X8
transducin-like enhancer protein 4 isoform X7
transducin-like enhancer protein 4 isoform X6
transducin-like enhancer protein 4 isoform X2
transducin-like enhancer protein 4 isoform X5
transducin-like enhancer protein 4 isoform X4
transducin-like enhancer protein 4 isoform X1
transducin-like enhancer protein 4 isoform X8
TLE family member 5-like, transcript variant X2
TLE family member 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122565104, transcript variant X1
uncharacterized LOC122565104, transcript variant X2
guanine nucleotide-binding protein G(q) subunit alpha
guanine nucleotide-binding protein subunit alpha-11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-11-like isoform X1
guanine nucleotide-binding protein subunit alpha-11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-14-like isoform X2
C2 calcium-dependent domain-containing protein 4C-like
ADAMTS-like protein 5, transcript variant X1
ADAMTS-like protein 5, transcript variant X2
uncharacterized LOC122565389, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122565389, transcript variant X5
uncharacterized LOC122565389, transcript variant X4
uncharacterized LOC122565389, transcript variant X3
uncharacterized LOC122565389, transcript variant X1
uncharacterized LOC122565389, transcript variant X6
proprotein convertase subtilisin/kexin type 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
proprotein convertase subtilisin/kexin type 4-like isoform X4
proprotein convertase subtilisin/kexin type 4-like, transcript variant X1
proprotein convertase subtilisin/kexin type 4-like, transcript variant X2
proprotein convertase subtilisin/kexin type 4-like isoform X2
proprotein convertase subtilisin/kexin type 4-like isoform X1
proprotein convertase subtilisin/kexin type 4-like, transcript variant X3
proprotein convertase subtilisin/kexin type 4-like isoform X3
receptor expression-enhancing protein 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor expression-enhancing protein 6-like, transcript variant X2
receptor expression-enhancing protein 6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
receptor expression-enhancing protein 6-like, transcript variant X3
receptor expression-enhancing protein 6-like isoform X3
receptor expression-enhancing protein 6-like isoform X2
receptor expression-enhancing protein 6-like isoform X4
receptor expression-enhancing protein 6-like isoform X1
receptor expression-enhancing protein 6-like
chromosome 31 C19orf25 homolog, transcript variant X1
chromosome 31 C19orf25 homolog, transcript variant X2
APC regulator of WNT signaling pathway 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
APC regulator of WNT signaling pathway 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
APC regulator of WNT signaling pathway 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adenomatous polyposis coli protein 2 isoform X2
adenomatous polyposis coli protein 2 isoform X1
adenomatous polyposis coli protein isoform X3
DAZ associated protein 1, transcript variant X3
DAZ associated protein 1, transcript variant X1
DAZ associated protein 1, transcript variant X2
DAZ associated protein 1, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00396
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
guanidinoacetate N-methyltransferase-like
NADH:ubiquinone oxidoreductase core subunit S7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
PWWP domain-containing DNA repair factor 3A-like, transcript variant X2
PWWP domain-containing DNA repair factor 3A-like, transcript variant X5
PWWP domain-containing DNA repair factor 3A-like, transcript variant X4
PWWP domain-containing DNA repair factor 3A-like, transcript variant X3
PWWP domain-containing DNA repair factor 3A-like, transcript variant X1
PWWP domain-containing DNA repair factor 3A-like, transcript variant X6
PWWP domain-containing DNA repair factor 3A-like isoform X4
PWWP domain-containing DNA repair factor 3A-like isoform X3
PWWP domain-containing DNA repair factor 3A-like isoform X2
PWWP domain-containing DNA repair factor 3A-like isoform X1
PWWP domain-containing DNA repair factor 3A-like isoform X5
calcium/calmodulin-dependent protein kinase type IV-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122565405, transcript variant X3
uncharacterized LOC122565405, transcript variant X1
uncharacterized LOC122565405, transcript variant X4
uncharacterized LOC122565405, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122565407, transcript variant X1
uncharacterized LOC122565407, transcript variant X2
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
mitochondrial contact site and cristae organizing system subunit 13
hydroxysteroid (11-beta) dehydrogenase 1-like a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
hydroxysteroid (11-beta) dehydrogenase 1-like a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hydroxysteroid 11-beta-dehydrogenase 1-like protein
cugbp, Elav-like family member 5a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cugbp, Elav-like family member 5a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CUGBP Elav-like family member 5a isoform X2
CUGBP Elav-like family member 5a isoform X1
HAUS augmin like complex subunit 8, transcript variant X1
HAUS augmin like complex subunit 8, transcript variant X2
HAUS augmin-like complex subunit 8 isoform X1
HAUS augmin-like complex subunit 8 isoform X2
HAUS augmin like complex subunit 8, transcript variant X3
HAUS augmin-like complex subunit 8 isoform X3
uncharacterized LOC122565419, transcript variant X3
uncharacterized LOC122565419, transcript variant X2
uncharacterized LOC122565419, transcript variant X4
uncharacterized LOC122565419, transcript variant X1
sphingosine-1-phosphate receptor 4, transcript variant X3
sphingosine-1-phosphate receptor 4, transcript variant X2
sphingosine-1-phosphate receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
small glutamine-rich tetratricopeptide repeat-containing protein alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X5
GTP-binding protein Di-Ras1, transcript variant X10
GTP-binding protein Di-Ras1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GTP-binding protein Di-Ras1, transcript variant X7
GTP-binding protein Di-Ras1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like, transcript variant X1
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like
growth arrest and DNA damage-inducible protein GADD45 beta-like
semaphorin-4E-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
semaphorin-4E-like, transcript variant X2
semaphorin-4E-like, transcript variant X1
semaphorin-4E-like, transcript variant X4
semaphorin-4E-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
semaphorin-4E-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X7
CTD small phosphatase-like protein 2, transcript variant X4
CTD small phosphatase-like protein 2, transcript variant X2
CTD small phosphatase-like protein 2, transcript variant X3
CTD small phosphatase-like protein 2, transcript variant X1
CTD small phosphatase-like protein 2, transcript variant X6
CTD small phosphatase-like protein 2 isoform X1
CTD small phosphatase-like protein 2 isoform X3
CTD small phosphatase-like protein 2, transcript variant X5
CTD small phosphatase-like protein 2 isoform X2
ceramide synthase 1, transcript variant X1
ceramide synthase 1, transcript variant X2
unconventional SNARE in the ER 1 homolog (S. cerevisiae)
insulin receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
insulin receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
insulin receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X7
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X6
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X5
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X1
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X3
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X2
rho guanine nucleotide exchange factor 18 isoform X1
rho guanine nucleotide exchange factor 18 isoform X6
rho guanine nucleotide exchange factor 18 isoform X5
rho guanine nucleotide exchange factor 18 isoform X3
rho guanine nucleotide exchange factor 18 isoform X2
rho/rac guanine nucleotide exchange factor (GEF) 18b, transcript variant X4
rho guanine nucleotide exchange factor 18 isoform X4
rho guanine nucleotide exchange factor 18 isoform X7
beta-1,4-galactosyltransferase 2-like, transcript variant X2
beta-1,4-galactosyltransferase 2-like, transcript variant X1
beta-1,4-galactosyltransferase 2-like isoform X2
beta-1,4-galactosyltransferase 2-like isoform X1
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3-like
uncharacterized LOC122565440, transcript variant X1
uncharacterized LOC122565440, transcript variant X2
uncharacterized LOC122565440, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 5 member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 5 member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 5 member 5, transcript variant X3
COUP transcription factor 1-like, transcript variant X2
COUP transcription factor 1-like, transcript variant X3
COUP transcription factor 1-like, transcript variant X1
COUP transcription factor 1-like isoform X1
COUP transcription factor 1-like isoform X2
COUP transcription factor 1-like isoform X3
hyaluronan and proteoglycan link protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neurocan core protein-like, transcript variant X1
neurocan core protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
regulatory factor X-associated ankyrin-containing protein, transcript variant X3
regulatory factor X-associated ankyrin-containing protein, transcript variant X2
regulatory factor X-associated ankyrin-containing protein, transcript variant X1
ankyrin repeat and LEM domain containing 1, transcript variant X2
ankyrin repeat and LEM domain-containing protein 1 isoform X2
ankyrin repeat and LEM domain containing 1, transcript variant X1
ankyrin repeat and LEM domain containing 1, transcript variant X4
ankyrin repeat and LEM domain-containing protein 1 isoform X1
ankyrin repeat and LEM domain-containing protein 1 isoform X4
ankyrin repeat and LEM domain containing 1, transcript variant X3
ankyrin repeat and LEM domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
39S ribosomal protein L34, mitochondrial
BLOC-1 related complex subunit 8, transcript variant X1
BLOC-1 related complex subunit 8, transcript variant X4
BLOC-1 related complex subunit 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
BLOC-1 related complex subunit 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
BLOC-1-related complex subunit 8 isoform X1
BLOC-1-related complex subunit 8 isoform X4
BLOC-1-related complex subunit 8 isoform X2
BLOC-1-related complex subunit 8 isoform X3
myocyte enhancer factor 2b, transcript variant X1
myocyte enhancer factor 2b, transcript variant X2
myocyte-specific enhancer factor 2B isoform X1
myocyte-specific enhancer factor 2B isoform X2
uncharacterized LOC122565455, transcript variant X3
uncharacterized LOC122565455, transcript variant X2
uncharacterized LOC122565455, transcript variant X1
uncharacterized LOC122565455, transcript variant X5
uncharacterized LOC122565455, transcript variant X4
uncharacterized LOC122565455, transcript variant X6
uncharacterized LOC122565455, transcript variant X7
transmembrane protein 161A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane protein 161A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 161A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
mitochondrial coenzyme A transporter SLC25A42
GATA zinc finger domain containing 2Ab, transcript variant X3
GATA zinc finger domain containing 2Ab, transcript variant X2
GATA zinc finger domain containing 2Ab, transcript variant X4
GATA zinc finger domain containing 2Ab, transcript variant X1
GATA zinc finger domain containing 2Ab, transcript variant X6
GATA zinc finger domain containing 2Ab, transcript variant X5
GATA zinc finger domain containing 2Ab, transcript variant X7
GATA zinc finger domain containing 2Ab isoform X1
GATA zinc finger domain containing 2Ab isoform X3
GATA zinc finger domain containing 2Ab isoform X4
GATA zinc finger domain containing 2Ab isoform X5
GATA zinc finger domain containing 2Ab isoform X2
testis-specific serine/threonine-protein kinase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
armadillo repeat-containing protein 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
armadillo repeat-containing protein 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
armadillo repeat-containing protein 6-like, transcript variant X2
armadillo repeat-containing protein 6-like
MAU2 sister chromatid cohesion factor, transcript variant X3
MAU2 sister chromatid cohesion factor, transcript variant X1
MAU2 chromatid cohesion factor homolog isoform X1
MAU2 chromatid cohesion factor homolog isoform X3
MAU2 sister chromatid cohesion factor, transcript variant X2
MAU2 chromatid cohesion factor homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cartilage intermediate layer protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cartilage intermediate layer protein 2, transcript variant X2
cartilage intermediate layer protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cartilage intermediate layer protein 1 isoform X1
cartilage intermediate layer protein 1 isoform X2
cartilage intermediate layer protein 1 isoform X3
DNA ligase 1-like, transcript variant X2
DNA ligase 1-like, transcript variant X1
deuterosome assembly protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
hippocampus abundant transcript 1 protein-like, transcript variant X1
hippocampus abundant transcript 1 protein-like isoform X1
hippocampus abundant transcript 1 protein-like, transcript variant X3
hippocampus abundant transcript 1 protein-like, transcript variant X2
hippocampus abundant transcript 1 protein-like isoform X2
vascular cell adhesion protein 1-like, transcript variant X1
vascular cell adhesion protein 1-like, transcript variant X2
vascular cell adhesion protein 1-like, transcript variant X3
vascular cell adhesion protein 1-like isoform X2
vascular cell adhesion protein 1-like isoform X3
arrestin domain-containing protein 2-like, transcript variant X2
arrestin domain-containing protein 2-like, transcript variant X1
arrestin domain-containing protein 2-like isoform X2
arrestin domain-containing protein 2-like isoform X1
ras-related protein Rab-3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ras-related protein Rab-3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X5
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X6
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X8
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X7
cAMP-specific 3',5'-cyclic phosphodiesterase 4C-like isoform X9
MPV17 mitochondrial inner membrane protein like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
SAC3 domain-containing protein 1-like, transcript variant X4
SAC3 domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
SAC3 domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SAC3 domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
elongation factor RNA polymerase II, transcript variant X1
RNA polymerase II elongation factor ELL isoform X1
elongation factor RNA polymerase II, transcript variant X2
RNA polymerase II elongation factor ELL isoform X2
FKBP prolyl isomerase 8, transcript variant X3
FKBP prolyl isomerase 8, transcript variant X2
FKBP prolyl isomerase 8, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP8 isoform X1
peptidyl-prolyl cis-trans isomerase FKBP8 isoform X2
unconventional myosin-IXb-like, transcript variant X2
unconventional myosin-IXb-like, transcript variant X1
unconventional myosin-IXb-like isoform X2
unconventional myosin-IXb-like isoform X1
unconventional myosin-IXb-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
unconventional myosin-IXb-like isoform X3
inositol-3-phosphate synthase 1-A-like, transcript variant X1
inositol-3-phosphate synthase 1-A-like, transcript variant X2
inositol-3-phosphate synthase 1-A-like, transcript variant X3
inositol-3-phosphate synthase 1-A-like, transcript variant X4
inositol-3-phosphate synthase 1-A-like isoform X1
inositol-3-phosphate synthase 1-A-like isoform X2
single-stranded DNA-binding protein 3-like, transcript variant X5
single-stranded DNA-binding protein 3-like, transcript variant X3
single-stranded DNA-binding protein 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
single-stranded DNA-binding protein 3-like, transcript variant X1
single-stranded DNA-binding protein 3-like, transcript variant X2
single-stranded DNA-binding protein 3-like, transcript variant X6
single-stranded DNA-binding protein 3-like isoform X3
single-stranded DNA-binding protein 3-like isoform X2
single-stranded DNA-binding protein 3-like isoform X1
single-stranded DNA-binding protein 3-like isoform X4
kelch-like ECH-associated protein 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
kelch-like ECH-associated protein 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kelch-like ECH-associated protein 1A isoform X2
kelch-like ECH-associated protein 1A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
required for excision 1-B domain containing
required for excision 1-B domain-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
microtubule-associated protein 1Sa, transcript variant X2
microtubule-associated protein 1Sa, transcript variant X1
electromotor neuron-associated protein 1 isoform X2
microtubule-associated protein 1S isoform X1
SURP and G-patch domain-containing protein 2-like, transcript variant X2
SURP and G-patch domain-containing protein 2-like, transcript variant X1
SURP and G-patch domain-containing protein 2-like isoform X2
SURP and G-patch domain-containing protein 2-like isoform X1
SURP and G-patch domain-containing protein 1
transmembrane 6 superfamily member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
small conductance calcium-activated potassium channel protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 2-like, transcript variant X2
small conductance calcium-activated potassium channel protein 2-like, transcript variant X1
small conductance calcium-activated potassium channel protein 2-like, transcript variant X5
small conductance calcium-activated potassium channel protein 2-like isoform X4
small conductance calcium-activated potassium channel protein 2-like isoform X3
small conductance calcium-activated potassium channel protein 2-like isoform X2
small conductance calcium-activated potassium channel protein 2-like isoform X1
small conductance calcium-activated potassium channel protein 2-like isoform X5
coiled-coil domain-containing protein 124
protein S100-A1-like, transcript variant X1
protein S100-A1-like, transcript variant X2
KxDL motif containing 1, transcript variant X2
kxDL motif-containing protein 1 isoform X2
KxDL motif containing 1, transcript variant X1
kxDL motif-containing protein 1 isoform X1
ubiquitin A-52 residue ribosomal protein fusion product 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
SHC (Src homology 2 domain containing) transforming protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SHC (Src homology 2 domain containing) transforming protein 2, transcript variant X2
tubulin polyglutamylase complex subunit 1
SIN3 transcription regulator family member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SIN3 transcription regulator family member B, transcript variant X2
paired amphipathic helix protein Sin3b isoform X1
paired amphipathic helix protein Sin3b isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49, transcript variant X2
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49, transcript variant X1
probable ATP-dependent RNA helicase DDX49 isoform X1
probable ATP-dependent RNA helicase DDX49 isoform X2
UPF1 RNA helicase and ATPase, transcript variant X2
UPF1 RNA helicase and ATPase, transcript variant X1
regulator of nonsense transcripts 1 isoform X2
regulator of nonsense transcripts 1 isoform X1
CREB-regulated transcription coactivator 1-like, transcript variant X2
CREB-regulated transcription coactivator 1-like, transcript variant X1
CREB-regulated transcription coactivator 1-like isoform X2
CREB-regulated transcription coactivator 1-like isoform X1
CREB-regulated transcription coactivator 1-like, transcript variant X3
CREB-regulated transcription coactivator 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
microtubule-associated serine/threonine-protein kinase 3-like
uncharacterized LOC122565521, transcript variant X2
uncharacterized LOC122565521, transcript variant X3
uncharacterized LOC122565521, transcript variant X1
gamma-interferon-inducible lysosomal thiol reductase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
bifunctional coenzyme A synthase isoform X1
bifunctional coenzyme A synthase isoform X2
bifunctional coenzyme A synthase isoform X3
MAX dimerization protein MLX, transcript variant X1
MAX dimerization protein MLX, transcript variant X3
MAX dimerization protein MLX, transcript variant X2
PSMC3 interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
PSMC3 interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
homologous-pairing protein 2 homolog isoform X3
homologous-pairing protein 2 homolog isoform X2
PSMC3 interacting protein, transcript variant X1
homologous-pairing protein 2 homolog isoform X1
pleckstrin homology, MyTH4 and FERM domain containing H3
pleckstrin homology domain-containing family H member 3
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
contactin associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
contactin associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
contactin associated protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
contactin associated protein 1, transcript variant X3
contactin-associated protein 1 isoform X1
contactin-associated protein 1 isoform X2
contactin-associated protein 1 isoform X4
contactin-associated protein 1 isoform X3